Exhale

The official blog of the Lung Institute.

Stage 1 COPD: Mild Stage COPD and You

10 Oct 2016
| Under COPD, Disease Education, Medical | Posted by | 10 Comments
Stage 1 COPD: Mild Stage COPD and You

Now that you know the general information about chronic obstructive pulmonary disease (COPD) and the COPD stages, prognosis and life expectancy, it’s important to understand how each stage is broken down. Each COPD stage differs in severity of symptoms, spirometry and COPD screening results and how COPD affects your life. In this article, we’ll focus on what you need to know about stage 1 COPD, which is also known as mild stage COPD.

Determining Stage 1 COPD

There are four total COPD stages, ranging from mild to very severe. Your doctor or pulmonologist will take a medical history, perform certain lung function tests and take into account how COPD affects your life to determine your stage of COPD.

Pulmonary function tests, which includes spirometry, will give lung function measurements to your doctor. Typically, doctors use the GOLD System and the BODE Index to help them categorize your stage of COPD.

Stage 1 COPD: Mild Stage COPD and You

In the GOLD System, stage 1 COPD is categorized as very mild COPD with a FEV1 (forced expiratory volume in one second) about 80 percent or more of normal lung capacity.

Stage 1 COPD

During stage 1 COPD, most people don’t notice many symptoms and don’t know there is a problem. Because stage 1 COPD is the mildest stage, you may not have noticed a decrease in lung function yet. Stage 1 COPD typically causes minor airflow limitation. However, you may start to see an increase in mucus production, or you might develop a chronic cough.

Many people with stage 1 COPD don’t visit their doctor to talk about their symptoms, leaving their COPD untreated. Because COPD is a progressive disease, meaning it will worsen over time, it’s essential to receive a COPD diagnosis and to begin a COPD treatment plan as soon as possible. Diagnosing and treating COPD early gives you the best chance to slow the progression of the disease and improve your quality of life. It also helps you and your doctor develop the best treatment plan for you.

Stage 1 COPD Treatment

Because COPD affects everyone differently and at different rates, your COPD treatment plan will likely change over time. Depending on your stage 1 COPD symptoms, your doctor may prescribe a variety of medications, such as bronchodilators, flu and pneumonia vaccines and others.

Your doctor may also recommend lifestyle modifications, such as quitting smoking, avoiding your COPD symptom triggers, eating a lung-healthy diet and getting enough exercise. These lifestyle modifications have been shown to help people with COPD live a more active life.

Stage 1 COPD: Mild Stage COPD and You

In combination with medications and lifestyle modifications, many people have benefited from trying alternative COPD treatments, such as chiropractic care, acupuncture and cellular therapy. Typically, medications work to manage and reduce COPD symptoms. However, cellular therapy works to promote healing from within the lungs, potentially improving breathing and quality of life.

Many patients report feeling better after treatment, are able to reduce their oxygen therapy use and can live a more active life doing their favorite activities. Cellular therapy can help people in any stage of COPD, from stage 1 COPD to end stage COPD. If you or a loved one has COPD, emphysema, chronic bronchitis or another chronic lung disease, contact us at (800) 729-3065 to learn more about your cellular therapy options.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.